English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Ovarian cancer is the third most common cancer in women after breast and uterine cancer. It remains the most lethal. Its severity, directly linked to the frequency of advanced forms and its prognosis, are conditioned by resectability. This pathology is the fourth cause of death from cancer in women according to the National Institute for Public Health Surveillance behind breast, colon and lung cancer with more than 3,000 deaths estimated in 2008 [1,2]. Survival at 5 years, all stages combined, is around 45% with a worse prognosis for stages III (between 20-40%) and IV (around 10%) [3,4].

journal of gynecology and womens health

Strategy for the Management and Prognosis of Ovarian Cancer in Sub-Saharan Africa: Experience from the National Hospital Center Of Pikine, Dakar-Senegal